M1483 is the authoritative medical code for Patients who achieve sustained virological response as identified by an hcv RNA test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv RNA result that occurred 20 weeks to 12 months after the first positive/detectable hcv RNA test result within the denominator identification period. This classification is used in medical billing and clinical recording to specify the clinical criteria for patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period (HCPCS Level II M1483), ensuring healthcare documentation aligns with current federal coding standards.

Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.

Medicare Coverage & Payment

Medicare coverage: Carrier judgment (CMS coverage code C)
Payment category: Service not separately priced (pricing indicator 00)
BETOS: Z2
Effective: January 1, 2026

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Official Registry Overview & Definition

Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period is a HCPCS Level II code (M1483) for a Medicare-covered supply, service, or procedure. Short description: Neg quan hep c or qual rna.

Nearest Codes in This Family

Official HCPCS Level II classifications closest to M1483 in its code family, with their registry titles.

M1478 — Psychoactive substance abuse
M1479 — Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders
M1480 — Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders
M1481 — Patients receiving hospice or palliative care or who died during the measurement period
M1482 — Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification period
M1484 — Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis)
M1485 — Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period
M1486 — Patients admitted to a skilled nursing facility (snf) during the period of evaluation
M1487 — Patients in hospice in the year before or during the period of evaluation
M1488 — Patients with a diagnosis for dementia in the year before or during the period of evaluation